ADVANCED SOLID TUMOR HISTORICALLY KNOWN FOR HIGH EPHA2 EXPRESSION

Clinical trials for ADVANCED SOLID TUMOR HISTORICALLY KNOWN FOR HIGH EPHA2 EXPRESSION explained in plain language.

Never miss a new study

Get alerted when new ADVANCED SOLID TUMOR HISTORICALLY KNOWN FOR HIGH EPHA2 EXPRESSION trials appear

Sign up with your email to follow new studies for ADVANCED SOLID TUMOR HISTORICALLY KNOWN FOR HIGH EPHA2 EXPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New targeted drug enters human trials for multiple advanced cancers

Disease control Ongoing

This early-stage study is testing a new drug called BT5528, both alone and combined with another cancer drug (nivolumab), in people with advanced solid tumors. The main goals are to find a safe dose and see what side effects occur. Researchers will also check if the drug helps sh…

Matched conditions: ADVANCED SOLID TUMOR HISTORICALLY KNOWN FOR HIGH EPHA2 EXPRESSION

Phase: PHASE1, PHASE2 • Sponsor: BicycleTx Limited • Aim: Disease control

Last updated Apr 04, 2026 07:35 UTC

ADVANCED SOLID TUMOR HISTORICALLY KNOWN FOR HIGH EPHA2 EXPRESSION

Get alerted when new ADVANCED SOLID TUMOR HISTORICALLY KNOWN FOR HIGH EPHA2 EXPRESSION trials appear

New targeted drug enters human trials for multiple advanced cancers